Literature DB >> 29285018

Additional evidence for the 'wimp SNP' concept of carcinogenesis.

Hermann M Bolt1.   

Abstract

Entities:  

Year:  2017        PMID: 29285018      PMCID: PMC5735334          DOI: 10.17179/excli2017-947

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

Dear Editor, In 2011 Klaus Golka and colleagues from Dortmund University published the wimp SNP concept of carcinogenesis (Golka et al., 2011[8]). According to this concept, individual genetic variants, usually SNPs, confer only a small cancer risk. However, specific combinations of high risk variants may interact, leading to a much higher risk of affected individuals. Although Golka and colleagues established this concept originally for urinary bladder cancer, it may in principle apply for all types of cancer and any polygenic disease. Until recently the wimp SNP concept was not much more than a fascinating hypothesis without comprehensive experimental proof. However, with the publication of a recent study including totally more than 10,000 cases and controls the situation has changed (Selinski et al., 2017[23]). Selinski and colleagues identified a statistical interaction of four high risk variants. Each of the individual high risk variants leads to an odds ratio of only 1.1-1.3. However, individuals that carry all four variants have a 2.6-fold increased risk. The four sequences, whose high risk variants interact, are a sequence near APOBEC3A, an exon of SLC14A1, an intron of UGT1A and a variant near CCNE1. Unfortunately, too little is known about each individual variant to understand the mechanism why they interact. However, the fact that wimp SNPs interact to cause high odds ratios has been confirmed. This progress has been made possible by numerous studies, mostly genome-wide association studies that have identified the individual high risk variants (e.g. Selinski, 2012[20], 2014[21][22]; Rafnar et al., 2009[15], 2011[17], 2014[16]; Kiemeney et al., 2008[12], 2010[11]; Garcia-Closas et al., 2011[6]; Figueroa et al., 2014[4], 2016[3]; Rothman et al., 2010[18]; Schwender et al., 2012[19]; Golka et al., 2011[8]). Currently, most studies on genetic polymorphisms in human disease still focus on individual variants (Huang et al., 2016[10]; Pellé et al., 2016[14]; Anvar et al., 2011[1]; Hashemi et al., 2015[9]; Liaqat et al., 2015[13]; Chu et al., 2016[2]; Fujihara et al., 2016[5]; Geller et al., 2016[7]). However, the recent study of Selinski et al. (2017[23]) has shown that identification of the most powerful interactions of individual SNPs is an attractive perspective of the post-GWAS era.
  23 in total

1.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

Authors:  Montserrat Garcia-Closas; Yuanqing Ye; Nathaniel Rothman; Jonine D Figueroa; Núria Malats; Colin P Dinney; Nilanjan Chatterjee; Ludmila Prokunina-Olsson; Zhaoming Wang; Jie Lin; Francisco X Real; Kevin B Jacobs; Dalsu Baris; Michael Thun; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Manolis Kogevinas; Ashish M Kamat; Seth P Lerner; H Barton Grossman; Jian Gu; Xia Pu; Amy Hutchinson; Yi-Ping Fu; Laurie Burdett; Meredith Yeager; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Joseph F Fraumeni; Debra T Silverman; Stephen J Chanock; Xifeng Wu
Journal:  Hum Mol Genet       Date:  2011-08-08       Impact factor: 6.150

2.  Urinary bladder cancer risk variants: recent findings and new challenges of GWAS and confirmatory studies.

Authors:  Silvia Selinski
Journal:  Arch Toxicol       Date:  2014-07       Impact factor: 5.153

3.  A functional variant in miR-143 promoter contributes to prostate cancer risk.

Authors:  Haiyan Chu; Dongyan Zhong; Jialin Tang; Jie Li; Yao Xue; Na Tong; Chao Qin; Changjun Yin; Zhengdong Zhang; Meilin Wang
Journal:  Arch Toxicol       Date:  2014-10-30       Impact factor: 5.153

Review 4.  Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".

Authors:  Klaus Golka; Silvia Selinski; Marie-Louise Lehmann; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Holger Schwender; Hermann M Bolt; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2011-03-05       Impact factor: 5.153

5.  Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.

Authors:  Jonine D Figueroa; Candace D Middlebrooks; A Rouf Banday; Yuanqing Ye; Montserrat Garcia-Closas; Nilanjan Chatterjee; Stella Koutros; Lambertus A Kiemeney; Thorunn Rafnar; Timothy Bishop; Helena Furberg; Giuseppe Matullo; Klaus Golka; Manuela Gago-Dominguez; Jack A Taylor; Tony Fletcher; Afshan Siddiq; Victoria K Cortessis; Charles Kooperberg; Olivier Cussenot; Simone Benhamou; Jennifer Prescott; Stefano Porru; Colin P Dinney; Núria Malats; Dalsu Baris; Mark P Purdue; Eric J Jacobs; Demetrius Albanes; Zhaoming Wang; Charles C Chung; Sita H Vermeulen; Katja K Aben; Tessel E Galesloot; Gudmar Thorleifsson; Patrick Sulem; Kari Stefansson; Anne E Kiltie; Mark Harland; Mark Teo; Kenneth Offit; Joseph Vijai; Dean Bajorin; Ryan Kopp; Giovanni Fiorito; Simonetta Guarrera; Carlotta Sacerdote; Silvia Selinski; Jan G Hengstler; Holger Gerullis; Daniel Ovsiannikov; Meinolf Blaszkewicz; Jose Esteban Castelao; Manuel Calaza; Maria Elena Martinez; Patricia Cordeiro; Zongli Xu; Vijayalakshmi Panduri; Rajiv Kumar; Eugene Gurzau; Kvetoslava Koppova; H Bas Bueno-De-Mesquita; Börje Ljungberg; Françoise Clavel-Chapelon; Elisabete Weiderpass; Vittorio Krogh; Miren Dorronsoro; Ruth C Travis; Anne Tjønneland; Paul Brennan; Jenny Chang-Claude; Elio Riboli; David Conti; Marianna C Stern; Malcolm C Pike; David Van Den Berg; Jian-Min Yuan; Chancellor Hohensee; Rebecca P Jeppson; Geraldine Cancel-Tassin; Morgan Roupret; Eva Comperat; Constance Turman; Immaculata De Vivo; Edward Giovannucci; David J Hunter; Peter Kraft; Sara Lindstrom; Angela Carta; Sofia Pavanello; Cecilia Arici; Giuseppe Mastrangelo; Ashish M Kamat; Liren Zhang; Yilei Gong; Xia Pu; Amy Hutchinson; Laurie Burdett; William A Wheeler; Margaret R Karagas; Alison Johnson; Alan Schned; G M Monawar Hosain; Molly Schwenn; Manolis Kogevinas; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Gerald Andriole; Robert Grubb; Amanda Black; W Ryan Diver; Susan M Gapstur; Stephanie Weinstein; Jarmo Virtamo; Christopher A Haiman; Maria Teresa Landi; Neil E Caporaso; Joseph F Fraumeni; Paolo Vineis; Xifeng Wu; Stephen J Chanock; Debra T Silverman; Ludmila Prokunina-Olsson; Nathaniel Rothman
Journal:  Hum Mol Genet       Date:  2016-01-04       Impact factor: 6.150

6.  A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.

Authors:  Nathaniel Rothman; Montserrat Garcia-Closas; Nilanjan Chatterjee; Nuria Malats; Xifeng Wu; Jonine D Figueroa; Francisco X Real; David Van Den Berg; Giuseppe Matullo; Dalsu Baris; Michael Thun; Lambertus A Kiemeney; Paolo Vineis; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Thorunn Rafnar; Michelle A T Hildebrandt; Anne E Kiltie; Olivier Cussenot; Klaus Golka; Rajiv Kumar; Jack A Taylor; Jose I Mayordomo; Kevin B Jacobs; Manolis Kogevinas; Amy Hutchinson; Zhaoming Wang; Yi-Ping Fu; Ludmila Prokunina-Olsson; Laurie Burdett; Meredith Yeager; William Wheeler; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; Victoria K Cortessis; Manuela Gago-Dominguez; Malcolm C Pike; Mariana C Stern; Jian-Min Yuan; David J Hunter; Monica McGrath; Colin P Dinney; Bogdan Czerniak; Meng Chen; Hushan Yang; Sita H Vermeulen; Katja K Aben; J Alfred Witjes; Remco R Makkinje; Patrick Sulem; Soren Besenbacher; Kari Stefansson; Elio Riboli; Paul Brennan; Salvatore Panico; Carmen Navarro; Naomi E Allen; H Bas Bueno-de-Mesquita; Dimitrios Trichopoulos; Neil Caporaso; Maria Teresa Landi; Federico Canzian; Borje Ljungberg; Anne Tjonneland; Francoise Clavel-Chapelon; David T Bishop; Mark T W Teo; Margaret A Knowles; Simonetta Guarrera; Silvia Polidoro; Fulvio Ricceri; Carlotta Sacerdote; Alessandra Allione; Geraldine Cancel-Tassin; Silvia Selinski; Jan G Hengstler; Holger Dietrich; Tony Fletcher; Peter Rudnai; Eugen Gurzau; Kvetoslava Koppova; Sophia C E Bolick; Ashley Godfrey; Zongli Xu; José I Sanz-Velez; María D García-Prats; Manuel Sanchez; Gabriel Valdivia; Stefano Porru; Simone Benhamou; Robert N Hoover; Joseph F Fraumeni; Debra T Silverman; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-10-24       Impact factor: 38.330

7.  Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

Authors:  Holger Schwender; Silvia Selinski; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Klaus Golka; Jan G Hengstler
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer.

Authors:  Silvia Selinski
Journal:  EXCLI J       Date:  2014-11-03       Impact factor: 4.068

9.  Polymorphism analysis in estrogen receptors alpha and beta genes and their association with infertile population in Pakistan.

Authors:  Sinha Liaqat; Shahida Hasnain; Saima Muzammil; Sumreen Hayat
Journal:  EXCLI J       Date:  2015-10-08       Impact factor: 4.068

10.  Macrophage migration inhibitory factor -173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran.

Authors:  Mohammad Hashemi; Batool Sharifi-Mood; Azam Rasouli; Shadi Amininia; Mohammad Naderi; Mohsen Taheri
Journal:  EXCLI J       Date:  2015-01-21       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.